Resources & News

Our Team Publications

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With NFPAs.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Due to the lack of hormonal hypersecretion, posttreatment follow-up evaluation of NFPAs is challenging. Read more

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Patients With Nonfunctioning Pituitary Adenomas: Executive Summary.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

A multidisciplinary task force composed of physician volunteers and evidence-based medicine-trained methodologists conducted a systematic review of the literature relevant to the management of NFPAs. The existing evidence provided valuable data upon which the guidelines described in the 7 articles generated from this effort are based. Read more

Update on the evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: the role of initial chemotherapy.

Child at Doctors

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Updates on treatment options to postpone the use of radiotherapy, to slow tumor growth and to improve progression free survival, overall survival (OS) and clinical symptoms. Read more

Neurocognitive functioning in patients with glioma of the left and right temporal lobes.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Patients with glioma frequently suffer from deficits of neurocognitive functioning (NCF), though few studies have assessed NCF in localized glioma patients prior to surgery. One hundred and three patients with histologically confirmed glioma in the right or left temporal lobe completed presurgical neuropsychological assessment. Impairment of NCF was identified in 75 % of all patients. Read more

Verbal Learning Processes in Patients with Glioma of the Left and Right Temporal Lobes.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Recent research supports the utility of process variables in understanding mechanisms underlying memory impairments. The Hopkins Verbal Learning Test-Revised (HVLT-R) was administered to 84 patients with left (LTL, n = 58) or right temporal lobe glioma (RTL, n = 26) prior to surgical resection. Primary HVLT-R measures of learning and memory and numerous learning process indices were computed. Read more

The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Chemotherapy is recommended as a treatment option to postpone the use of radiotherapy, to slow tumor growth and to improve progression free survival (PFS), overall survival (OS) and clinical symptoms in adult patients with newly diagnosed LGG. Who are the patients with newly diagnosed LGG that would benefit the most from chemotherapy? Read more

The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Child at Doctors

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Stereotactic biopsy is recommended when definitive surgical resection is limited by lesions that are deep-seated, not resectable, and/or located within eloquent cortex, or in patients unable to undergo craniotomy due to medical co-morbidities to obtain the critical tissue diagnosis needed for targeted treatment planning for patients with low-grade gliomas. Read more

Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Little is known regarding the neurocognitive impact of temporal lobe tumor resection. In patients with temporal lobe glioma, NCF decline in the subacute postoperative period is common. Read more

Zoledronic acid therapy for recurrent giant cell tumor of the C2 vertebra in an adolescent.

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Recurrent giant cell tumor (GCT) of the cervical spine represents a significant therapeutic challenge. In this case, computed tomography and magnetic resonance imaging of the cervical spine showed massive recurrence of the tumor with soft tumor mass compressing the spinal cord, osteolytic lesion of the right C1 lateral mass, and complete osteolytic destruction of the C3 vertebral body. Read more

Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.

Dr. Ziu at the Pituitary Care Center at Seton Brain & Spine Institute

Authors include Dr. Mateo Ziu, Seton Healthcare Family.

Compared with patients with grade II or III left temporal lobe glioma, patients with grade IV tumors exhibit greater difficulty with verbal learning, processing speed, executive functioning, and language. Read more

Neurosurgeon: Austin has chance to be a haven for cancer fighters.

Authored by Dr. Mateo Ziu, Seton Healthcare Family.

Cancer is the second-leading cause of death in the U.S. after heart disease. There will be an estimated 1.7 million new patients diagnosed with cancer in this country in 2016, and an estimated 600,000 will die from the disease this year, according to the American Cancer Society. In our long-standing fight against cancer, we’ve certainly learned a lot. But we’ve got quite a way to go. Read more

Helpful Links

American Brain Tumor Association: A non-profit organization dedicated to eliminating brain tumors by funding and encouraging research. Provides educational materials and information to patients, their families, and medical professionals. 800-886-ABTA (2282)

National Brain Tumor Society: A non-profit organization that provides leadership within the brain tumor community and strives to improve the quality of life for those affected by brain tumors. NBTS provides educational materials and information to patients, their families, and medical professionals. 617-924-9997